Goldman Sachs Lifts Price Target On Alexion Pharmaceuticals (ALXN) to $83

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. BILL
3. EL
4. MRK
5. MRNA
6. ADI
7. JKHY
8. LOW
9. COTY
10. RARE

January 23, 2012 2:43 PM EST
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%

Rating Summary:
    10 Buy, 25 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Goldman Sachs raised its price target earlier on Buy-rated Alexion Pharmaceuticals (NASDAQ: ALXN) from $76 to $83 saying they expect Soliris to keep delivering and added the HUS opportunity to their model.

For an analyst ratings summary and ratings history on Alexion Pharmaceuticals click here. For more ratings news on Alexion Pharmaceuticals click here.

Shares of Alexion Pharmaceuticals closed at $73.58 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Goldman Sachs